Lillian Nordahl

Lillian Nordahl is Managing Director and Co-Portfolio Manager at Great Point Partners in New York, where she co-leads the firm's BioMedical Value Fund (BMVF) investment strategy. Her core responsibilities include identifying, evaluating, and managing investments in the healthcare sector, with a particular focus on biopharmaceutical companies and related life sciences industries.

Prior to her current role, Ms. Nordahl served as Principal at Great Point Partners from 2015 to 2024, and previously worked as a healthcare investment banking analyst at Guggenheim Securities, where she specialized in equity financings and M&A advisory for biopharmaceutical firms. She is known for her expertise in fundamental company analysis and her in-depth understanding of biotech capital markets.

Lillian holds an MPhil in Pharmacology from the University of Cambridge and a BA in Molecular Biology and East Asian Studies from Princeton University. Her academic background and investment experience have established her as a specialist in biopharma and healthcare investing, and she has contributed to the successful growth and management of multiple healthcare companies through both public and private equity investments.